Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pain × naloxegol × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Opioid-Induced Constipation 6 Neoplasms 3 Constipation 2 Pain 1 Cancer Pain 1

Interventions

alvimopan 3 oxycodone naloxone combination 1 naloxegol 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Xylitol 1 Quality of Life 1 Oxycodone 1 Nicotine 1 Naloxone 1 Lidocaine 1 Ketamine 1 Injections 1 Gelclair 1 Exercise Movement Techniques 1 Diphenhydramine 1 Betaine 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02839889 2019-03-05

Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

Hospice of Henderson County, Inc.

Phase 4 Terminated

12 enrolled 33 charts

Constipation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡